Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

NCT07719088 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Aging
Longevity
Biomarkers of Aging

Interventions

DRUG: Psilocybin (Usona Institute)

Sponsor

Charles Raison

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]